&lt;IMS International Inc> said itsApplied Bioscience International Inc &lt;APBI> unit is making aninitial public offering of three mln shares of common stock at15 dlrs a share.    The offering, through a syndicate managed by ShearsonLehman Bros Inc and L.F. Rothschild Unterberg Towbin Inc,consists of IMS's entire holdings.    The unit is a toxicological testing company that haslaboratories in the U.S. and U.K. It is parent to Bio/dynamicsInc and Life Science Research Ltd, which were previously theLife Sciences division of IMS International. Reuter&#3;